Platelet antibodies and diagnosis of immune-mediated thrombocytopenia

Infusionstherapie und Transfusionsmedizin

Volumn 28, Issue 4, 2001, Pages 209-217

  Kiefel, V ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Autoimmune thrombocytopenic purpura; Drug induced immune thrombocytopenic purpura; Neonatal alloimmune thrombocytopenic purpura; Platelet glycoprotein Ia IIa; Platelet glycoprotein Ib IX; Platelet glycoprotein IIb IIIa; Post transfusion purpura

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; CARBAMAZEPINE; COTRIMOXAZOLE; DICLOFENAC; FIBRINOGEN RECEPTOR; HEPARIN; HLA ANTIGEN CLASS 1; IBUPROFEN; NOMIFENSINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; QUINIDINE; QUININE; RANITIDINE; RIFAMPICIN; THROMBIN RECEPTOR; THROMBOCYTE ANTIBODY; VANCOMYCIN;

ALLOIMMUNIZATION; BLEEDING DISORDER; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; DRUG INDUCED DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; NEWBORN; PATHOGENESIS; REVIEW; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

CINCHONA PUBESCENS; PURPURA;

EID: 0034874881     PISSN: 14245485     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050240     Document Type: Review

References (85)

1. Removal of HLA-A, B antigens from platelets
2. New approach to eliminate HLA class I antigen from platelet surface without cell damage: Acid treatment at pH 3.0
3. Influence of chloroquine or acid treatment of human platelets on the antigenicity of HLA and the 'thrombocyte-specific' glycoproteins Ia/IIa, IIb, and IIb/IIIa
4. The kinetics of HLA class I elution and the relevance for the use of HLA-eluted platelet transfusions
5. Biosynthesis of major platelet proteins in human blood platelets
6. The presence of messenger RNA for HLA class I in human platelets and its capability for protein biosynthesis
7. Quantitative analysis of platelet surface HLA by w6/32 anti-HLA monoclonal antibody
8. Expression of HLA-B12 on platelet, on lymphocytes and in serum: A quantitative study
9. A new platelet-specific antigen, Nak(a), involved in the refractoriness of HLA-matched platelet transfusion
10. Specificity of autoantibodies in autoimmune thrombocytopenia
11. Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP
12. Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura
13. Autoantibodies against platelet glycoprotein Ib/IX: A frequent finding in autoimmune thrombocytopenic purpura
14. Varicella-associated thrombocytopenia: Autoantibodies against platelet surface glycoprotein V
15. Autoimmune thrombocytopenia associated with B-CLL and an IgG autoantibody directed against the human platelet GP Ia-IIa complex (VLA-2)
16. Lack of platelet response to collagen associated with an autoantibody against glycoprotein Ia: A novel cause of acquired qualitative platelet dysfunction
17. Microdroplet assay of human serum cytotoxins
18. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): A new tool for the identification of platelet reactive antibodies
19. A specific assay for anti-HLA antibodies: Application to platelet donor selection
20. Reactivity of twenty-two cytotoxic human monoclonal HLA antibodies towards soluble HLA class I in an enzyme-linked immunosorbent assay (PRA-STAT(R))
21. Detection of HLA-specific antibodies by PRA-STAT and their association with transplant outcome
22. Discrimination of antibodies against antigens of different MHC loci in human sera by monoclonal antibody-specific immobilization of leukocyte antigens
23. International agreement of platelet complement fixation (Pl.C Fix.)
24. A simple immunofluorescence test for the detection of platelet antibodies
25. Microplate enzyme immuno-assay for detection of platelet antibodies
26. Studies on the platelet radioactive anti-immunoglobulin test
27. Chloroquine removal of HLA antigens from platelets for the platelet immunofluorescence test
28. Quantitation of platelet antigens after chloroquine treatment
29. Immunoblotting: An emerging technique in immunohematology
30. Immunochemical characterization of platelet-specific alloantigens
31. Immuno-chemical characterization of the new platelet alloantigen system Br(a)/Br(b)
32. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP
33. Report on the Tenth International Platelet Genotyping and Serology Workshop on behalf of the International Society of Blood Transfusion
34. Blood group A and B determinants are expressed on platelet glycoproteins IIa, IIIa, and Ib
35. Detection of platelet autoantibodies by a radioactive anti-immunoglobulin test
36. Immune thrombocytopenia: Use of a (125)I-labeled antihuman IgG monoclonal antibody to quantify platelet-bound IgG
37. Autoimmune thrombocytopenia: Detection of platelet autoantibodies with the suspension immunofluorescence test
38. Detection and quantification of platelet-bound antibodies with immunoperoxidase
39. Quantitative determination of antibody in idiopathic thrombocytopenic purpura. Correlation of serum and platelet-bound antibody with clinical response
40. Immunoglobulin associated with human platelets
41. Competitive enzyme-linked immunoassay for the quantitation of platelet-associated immunoglobulins (IgG, IgM, IgA) and complement (C3c, C3d)
42. The clinical significance of platelet-associated IgG: Aa study on 298 patients with various disorders
43. Immune thrombocytopenic purpura: Autoimmune or immune complex disease?
44. Elevated platelet-associated IgG in the thrombocytopenia of septicemia
45. The amount of platelet-bound albumin parallels the amount of IgG on washed platelets from patients with immune thrombocytopenia
46. Interference of IgG, IgG aggregates and immune complexes in tests for platelet autoantibodies
47. Platelet autoantibodies (IgG, IgM, IgA) against glycoproteins IIb/IIIa and Ib/IX in patients with thrombocytopenia
48. International study to compare antigen-specific methods used for the measurement of antiplatelet autoantibodies
49. Cyclic thrombocytopenia associated with IgM anti-GPIIb-IIIa autoantibodies
50. Cyclic thrombocytopenia of apparent autoimmune etiology
51. Menstrual cyclic thrombocytopenia
52. Acquired thrombasthenia due to GP IIb/IIIa-specific autoantibodies
53. Autoantibody against platelet glycoprotein IIb/IIIa in a patient with non-Hodgkin's lymphoma
54. Acquired disorder of platelet function associated with autoantibodies against membrane glycoprotien IIb-IIIa complex. 1. Glycoprotein analysis
55. Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen
56. Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia
57. Metabolite-specific (IgG) and drug-specific antibodies (IgG, IgM) in two cases of trimethoprim-sulfamethoxazole-induced immune thrombocytopenia
58. Immune thrombocytopenia due to a drug metabolite
59. Immune thrombocytopenia associated with hemorrhagic diathesis due to ibuprofen administration
60. Thrombocytopenia associated with gold therapy: A drug-induced autoimmune disease
61. Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentrates
62. Selection of unrelated compatible platelet donors by lymphocyte HL-A matching
63. Identification of antibodies toward private and public class I HLA epitopes in sensitized patients
64. Human platelet-specific alloantigens: Update
65. Maternal anti-HLA antibodies and neonatal thrombocytopenia
66. 348 Cases of suspected neonatal alloimmune thrombocytopenia
67. Neonatal alloimmune thrombocytopenia due to anti-HPA 1a antibodies; the level of maternal antibodies predicts the severity of thrombocytopenia in the newborn
68. Posttransfusionelle Purpura: Klinische und immunologische Untersuchungen bei 38 Patientinnen
69. Posttransfusion purpura due to an alloantibody reactive with glycoprotein Ia/IIa (anti-HPA-5b)
70. Transfusion reaction with severe thrombocytopenia due to a passively acquired platelet specific antibody
71. Post-transfusion purpura secondary to passive transfer of anti-P1(A1) by blood transfusion
72. Post-transfusion thrombocytopenia associated with passive transfusion of a platelet-specific antibody
73. Thrombocytopenia caused by passive transfusion of anti-glycoprotein Ia/IIa alloantibody (anti-HPA-5b)
74. Graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation
75. Immune thrombocytopenia more than a year after allogeneic marrow transplantation due to antibodies against donor platelets with anti-Pl(A1) specificity: Evidence for a host-derived immune reaction
76. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease
77. Human platelet alloantigen (HPA)-5a/b mismatch decreases disease-free survival in unrelated bone marrow transplantation
78. Alloantigene von thrombozyten
79. Platelet antibody in autoimmune thrombocytopenia
80. A new method for the simultaneous quantitation of platelet-bound immunoglobulin (IgG) and complement (C3) employing an enzyme-linked immunosorbent assay procedure
81. Simultaneous enzymo-immunologic assays of platelet associated IgG, IgM, and C3. A useful tool in assessment of immune thrombocytopenias
82. Quantitation of platelet-associated IgG by radial immunodiffusion
83. Enzyme-linked immunoassay for the detection of platelet associated IgG
84. Direct quantitation of platelet-associated IgG by electroimmunoassay
85. Evaluation by quantitative acid elution and radioimmunoassay of multiple classes of immunoglobulins and serum albumin associated with platelets in idiopathic thrombocytopenic purpura